편두통 환자를 위한 두통교육과 평가
Headache Education and Assessment for Migraineurs
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Migraine is a common neurologic disorder with recurrent headache and variable accompanying symptoms. Patients with migraine have suffered by an enormous burden on daily life and impairment of quality of life (QoL), but migraine is still underdiagnosed and undertreated. For early and better diagnosis and treatment of migraine, headache education and instruments for evaluation of headache outcomes including QoL and disability are essential. Nonpharmachological treatment like cognitive-behavior therapy, mindfulness-based stress reduction, lifestyle modification and trigger avoidance, biofeedback, relaxation training can reduce frequency of pain, disability, so headache education might be helpful. Headache diary and instruments for evaluation of QoL, disability and comorbidity like Migraine Disability Assessment Scale (MIDAS), Headache Impact Test-6 (HIT-6), Migraine-Specific Quality of Life Questionnaire (MSQ) are useful tools to decide plans of treatment. When nonpharmachological treatment and headache education are well applied and evaluation of the QoL and disability are reflected, it will help improve the quality of life for migraine patients.
Abstract
Migraine is a common neurologic disorder with recurrent headache and variable accompanying symptoms. Patients with migraine have suffered by an enormous burden on daily life and impairment of quality of life (QoL), but migraine is still underdiagnosed and undertreated. For early and better diagnosis and treatment of migraine, headache education and instruments for evaluation of headache outcomes including QoL and disability are essential. Nonpharmachological treatment like cognitive-behavior therapy, mindfulness-based stress reduction, lifestyle modification and trigger avoidance, biofeedback, relaxation training can reduce frequency of pain, disability, so headache education might be helpful. Headache diary and instruments for evaluation of QoL, disability and comorbidity like Migraine Disability Assessment Scale (MIDAS), Headache Impact Test-6 (HIT-6), Migraine-Specific Quality of Life Questionnaire (MSQ) are useful tools to decide plans of treatment. When nonpharmachological treatment and headache education are well applied and evaluation of the QoL and disability are reflected, it will help improve the quality of life for migraine patients.
참고문헌 (46)
- GBD 2015 Neurological Disorders Collaborator Group, "Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015", Lancet Neurol, 16, pp.877~897 (2017)
- Cha MJ, "Economic burden and cost of migraine", Korean J Headache, 19, pp.48~50 (2018)
- Holland S, "Rates and reasons for discontinuation of triptans and opioids in episodic migraine : results from the American Migraine Prevalence and Prevention(AMPP)study", J Neurol Sci, 326, pp.10~17 (2013)
- Blumenfeld AM, "Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine : results from the second international burden of migraine study(IBMS-II)", Headache, 53, pp.644~655 (2013)
- Singer AB, "Behavioral treatments for migraine management : useful at each step of migraine care", Curr Neurol Neurosci Rep, 15, pp.14~ (2015)
- Cho SJ, "Treatment update of chronic migraine", Curr Pain Headache Rep, 21, pp.26~ (2017)
- Orr SL, "Paediatric migraine : evidence-based management and future directions", Nat Rev Neurol, 14, pp.515~527 (2018)
- Lagman-Bartolome AM, "Headache education active-waiting directive : a program to enhance well-being during long referral wait times", Headache, 58, pp.109~117 (2018)
- Patel S, "Development of an education and self-management intervention for chronic headache-CHESS trial(Chronic Headache Education and Self-management Study)", J Headache Pain, 20, pp.28~ (2019)
- Beaton-Starr M, "Development and implementation of the integrative toolbox for headache management", Headache, 60, pp.771~775 (2020)
- Antonaci F, "Lessons from placebo effects in migraine treatment", J Headache Pain, 8, pp.63~66 (2007)
- Luedtke K, "Outcome measures for assessing the effectiveness of non-pharmacological interventions in frequent episodic or chronic migraine : a Delphi study", BMJ Open, 10, pp.e029855~ (2020)
- Drossman DA, "Presidential address : gastrointestinal illness and the biopsychosocial model", Psychosom Med, 60, pp.258~267 (1998)
- Seng EK, "Behavioral migraine management modifies behavioral and cognitive coping in people with migraine", Headache, 54, pp.1470~1483 (2014)
- Ost LG, "Cognitive behavior therapy for anxiety disorders : 40 years of progress", Nord J Psychiatry, 62(Suppl 47), pp.5~10 (2008)
- Anholt GE, "Cognitive versus behavior therapy : processes of change in the treatment of obsessive-compulsive disorder", Psychother Psychosom, 77, pp.38~42 (2008)
- Fava GA, "Six-year out-come of cognitive behavior therapy for prevention of recurrent depression", Am J Psychiatry, 161, pp.1872~1876 (2004)
- Leichsenring F, "The effectiveness of psychodynamic therapy and cognitive behavior therapy in the treatment of personality disorders : a meta-analysis", Am J Psychiatry, 160, pp.1223~1232 (2003)
- Nestoriuc Y, "Efficacy of biofeedback for migraine : a meta-analysis", Pain, 128, pp.111~127 (2007)
- Stokes DA, "Neurofeedback and biofeedback with 37 migraineurs : a clinical outcome study", Behav Brain Funct, 6, pp.9~ (2010)
- Yuen AW, "Can natural ways to stimulate the vagus nerve improve seizure control?", Epilepsy Behav, 67, pp.105~110 (2017)
- Gewirtz A, "Adherence to behavioral therapy for migraine : knowledge to date, mechanisms for assessing adherence, and methods for improving adherence", Curr Pain Headache Rep, 23, pp.3~ (2019)
- Rosenzweig S, "Mindfulness-based stress reduction for chronic pain conditions : variation in treatment outcomes and role of home meditation practice", J Psychosom Res, 68, pp.29~36 (2010)
- Wells RE, "Meditation for migraines : a pilot randomized controlled trial", Headache, 54, pp.1484~1495 (2014)
- Lee SH, "Mindfulness-based cognitive therapy for patients with migraine", Korean J Headache, 20, pp.37~41 (2019)
- Woldeamanuel YW, "The impact of regular lifestyle behavior in migraine : a prevalence case-referent study", J Neurol, 263, pp.669~676 (2016)
- Irby MB, "Aerobic exercise for reducing migraine burden : mechanisms, markers, and models of change processes", Headache, 56, pp.357~369 (2016)
- Varkey E, "Exercise as migraine prophylaxis : a randomized study using relaxation and topiramate as controls", Cephalalgia, 31, pp.1428~1438 (2011)
- Baillie LE, "A systematic review of behavioral headache interventions with an aerobic exercise component", Headache, 54, pp.40~53 (2014)
- May A, "Chronic migraine : risk factors, mechanisms and treatment", Nat Rev Neurol, 12, pp.455~464 (2016)
- Louter MA, "Cutaneous allodynia as a predictor of migraine chronification", Brain, 136, pp.3489~3496 (2013)
- Cervoni C, "Behavioral weight loss treatments for individuals with migraine and obesity", Curr Pain Headache Rep, 20, pp.13~ (2016)
- Tassorelli C, "Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults", Cephalalgia, 38, pp.815~832 (2018)
- Silberstein SD, "Practice parameter : evidence-based guidelines for migraine headache(an evidence-based review) : report of the Quality Standards Subcommittee of the American Academy of Neurology", Neurology, 55, pp.754~762 (2000)
- Park JW, "Analysis of trigger factors in episodic migraineurs using a smartphone headache diary applications", PLoS One, 11, pp.e0149577~ (2016)
- Stewart WF, "Development and testing of the migraine disability assessment(MIDAS)questionnaire to assess headache-related disability", Neurology, 56, pp.S20~S28 (2001)
- Stewart WF, "Validity of the migraine disability assessment(MIDAS)score in comparison to a diary-based measure in a population sample of migraine sufferers", Pain, 88, pp.41~52 (2000)
- Lee HS, "The reliability and validity of the MIDAS(migraine disability assessment)questionnaire for Korean migraine sufferers", J Korean Neurol Assoc, 18, pp.287~291 (2000)
- Kosinski M, "A six-item short-form survey for measuring headache impact : the HIT-6", Qual Life Res, 12, pp.963~974 (2003)
- 주민경, "한국어판 두통영향 검사(Headache Impact Test-6)의 타당도 및 신뢰도 조사", 대한신경과학회지, 27(1), pp.1~6 (2009), 대한신경과학회
- Martin BC, "Validity and reliability of the migraine-specific quality of life questionnaire (MSQ version 2.1)", Headache, 40, pp.204~215 (2000)
- Seo JG, "Validation of the Korean migraine-specific quality of life questionnaire version 2.1 in episodic and chronic migraine", J Oral Facial Pain Headache, 31, pp.251~256 (2017)
- Seo JG, "Validation of the patient health questionnaire-9(PHQ-9)and PHQ-2 in patients with migraine", J Headache Pain, 16, pp.65~ (2015)
- Kroenke K, "The PHQ-9 : validity of a brief depression severity measure", J Gen Intern Med, 16, pp.606~613 (2001)
- Spitzer RL, "A brief measure for assessing generalized anxiety disorder : the GAD-7", Arch Intern Med, 166, pp.1092~1097 (2006)
- Seo JG, "Validation of the generalized anxiety disorder-7(GAD-7)and GAD-2 in patients with migraine", J Headache Pain, 16, pp.97~ (2015)